LAUREN BALL: Open Payments
NPI 1871051664 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 38 payments from 16 companies in 2025. Trend: 2023 $2,818 · 2024 $616 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $328 |
| Endo USA, Inc. | 5 | $124 |
| Antares Pharma, Inc. | 5 | $82 |
| Boston Scientific Corporation | 2 | $66 |
| Verity Pharmaceuticals Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $46 |
| Olympus America Inc. | 2 | $44 |
| TOLMAR, INC. | 1 | $28 |
| Teleflex LLC | 1 | $27 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $25 |
Products named: GEMTESA, XIAFLEX, XYOSTED, Trelstar, iTIND System, Lumenis Pulse 120H, ORGOVYX, ELIGARD.
Industry payments across TN — which companies pay providers there.
